Blastomyces dermatitidis Antibodies by EIA, Serum

CPT: 86612
Print Share

Synonyms

  • Blastomyces Total antibodies

Expected Turnaround Time

2 - 4 days


Specimen Requirements


Specimen

Serum


Volume

1.0 mL


Minimum Volume

0.5 mL


Container

Gel-barrier tube, serum from a gel-barrier tube, serum from a red-top tube, serum transfer tube


Stability Requirements

Temperature

Period

Room temperature

14 days

Refrigerated

14 days

Frozen

14 days

Freeze/thaw cycles

Stable x3


Causes for Rejection

Gross hemolysis; grossly lipemic


Test Details


Use

Aid in the diagnosis of Blastomyces dermatitidis infection. Diagnosis of Blastomycosis relies on a combination of assays, including culture and molecular testing on appropriate specimens and serologic evaluation for both antibodies to and antigen released from Blastomyces. Although culture remains the gold standard method and is highly specific, the organism can take several days to weeks to grow, and sensitivity is diminished in cases of acute or localized disease. Similarily, molecular testing offers high specificity and a rapid turnaround time, however, sensitivity is imperfect. Detection of an antibody response to Blastomyces offers high specificity, however, results may be falsely negative in acutely infected patients and in immunosuppressed patients.

A positive result indicates that IgG and/or IgM antibodies to Blastomyces were detected. The presence of antibodies is presumptive evidence that the patient was or is currently infected with (or was exposed to) Blastomyces. A negative result indicates that antibodies to Blastomyces were not detected. The absence of antibodies is presumptive evidence that the patient was not infected with Blastomyces. However, the specimen may have been obtained before antibodies were detectable or the patient may be immunosuppressed. If infection is suspected, another specimen should be collected 7 to 14 days later and submitted for testing. Specimens testing positive or equivocal may be submitted for further testing by another conventional serologic test such as Blastomyces Antibodies, Quantitative, DID [164293].


Limitations

A negative result does not prelude a diagnosis of blastomycosis, particularily if only a single specimen has been tested and the patient shows symptoms consistent with positive diagnosis.

Cross-reactivity may occur with other fungal infections such as Aspergillus, Coccidioides, or Histoplasma.


Methodology

EIA


Reference Interval

Negative


References

Chapman SW. Blastomyces dermatitidis, p.2733-2746. In G.L. Mandell, J.E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 5th ed. Churchill Livingstone, Philadelphia, PA; 2000.
Reiss E, Kauffman L, Kovacs J, Lindsley M. Clinical Immunomycology, p.559-583. In N. Rose, R. Hamilton, and B. Detrick (ed.), Manual of Clinical Laboratory Immunology. ASM Press, Washington D.C.; 2002.
Saccente M, Woods GL. Clinical and Laboratory update on blastomycosis. Clin Microbiol Rev. 2010 Apr;23(2):367-381.20375357

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
165048 Blastomyces Ab EIA 7816-2 165049 Blastomyces Ab EIA 7816-2

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf